When co-cultured with B-ALL cell lines and primary B-ALL cells, CD19-CAR T cells maintained their ability to lyse target cells and produce pro-inflammatory cytokines, regardless of the presence of BM-MSCs from either HD or B-ALL patients [31]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.